« Previous
Next »
Ophthalmology
Volume 117, Issue 9
, Pages
1674-1683
, September 2010
Predicting the Onset of Glaucoma: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study
To access this article, please choose from the options below
Manuscript no. 2009-1585.
Financial Disclosure(s): The authors have made the following disclosures.
R.N. Weinreb - Support - Heidelberg Engineering, GmbH.
L.M. Zangwill - Support - Heidelberg Engineering, Heidelberg, Germany; Carl Zeiss Meditec Inc, Dublin, CA.
J. Piltz - Support - Seymour, Pfizer, Inc., Alcon Laboratories, Inc., Allergan, Inc., Merck.
G.A. Cioffi - Consultant - Allergan, Inc., Pfizer Inc, C.
G.L. Trick - Consultant - Allergan, Inc.
A.L. Coleman - Consultant - Alcon Laboratories, Inc., Allergan, Inc., Pfizer, Inc.
J.D. Brandt - Consultant - Alcon Laboratories, Inc., Allergan, Inc., Pfizer, Inc.; Lecturer - Alcon Laboratories, Inc., Allergan, Inc., Pfizer, Inc.
J.M. Liebmann - Consultant - Alcon Laboratories, Inc., Allergan, Inc., Optovue, Inc., Heidelberg Engineering, GmbH, Pfizer, Inc., Topcon Medical Systems, Inc., Diopsys, Inc.; Support - Carl Zeiss Meditec, Inc.; Diopsys, Inc., Heidelberg Engineering, GmbH, Optovue, Inc., Pfizer, Inc., Topcon Medical Systems, Inc.
M.A. Kass – Consultant – Pfizer, Inc.
Supported by NIH/NEI grants, EY11158 (RNW), (EY09341, EY09307 [MOG, MAK]), Horncrest Foundation awards, NIH Vision Core Grant P30 EY02687, Merck Research Laboratories, Pfizer Inc, White House Station, New Jersey.
PII: S0161-6420(10)00323-4
doi: 10.1016/j.ophtha.2010.03.044
© 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Ophthalmology
Volume 117, Issue 9
, Pages
1674-1683
, September 2010

